Head to Head Contrast: Pheton (NASDAQ:PTHL) vs. InnovAge (NASDAQ:INNV)

Pheton (NASDAQ:PTHL) and InnovAge (NASDAQ:INNV) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their institutional ownership, earnings, risk, profitability, dividends, analyst recommendations and valuation.

Institutional and Insider Ownership

12.3% of InnovAge shares are owned by institutional investors. 1.4% of InnovAge shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Profitability

This table compares Pheton and InnovAge’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Pheton	N/A	N/A	N/A
InnovAge	-3.75%	-11.91%	-5.85%

Analyst Recommendations

This is a summary of current ratings and recommmendations for Pheton and InnovAge, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Pheton	0	0	0	0	0.00
InnovAge	1	1	0	0	1.50

InnovAge has a consensus target price of $5.00, suggesting a potential upside of 31.93%. Given InnovAge’s stronger consensus rating and higher possible upside, analysts clearly believe InnovAge is more favorable than Pheton.

Earnings & Valuation

This table compares Pheton and InnovAge”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Pheton	$450,000.00	14.91	-$660,000.00	N/A	N/A
InnovAge	$763.85 million	0.67	-$21.34 million	($0.23)	-16.48

Pheton has higher earnings, but lower revenue than InnovAge.

About Pheton

Pheton Holdings Ltd. operates as a holding company with interests in providing healthcare solutions. The firm through its subsidiaries engages in the development and commercialization of brachytherapy TPS specifically used for radioactive particle implantation, a type of radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company was founded in 1998 and is headquartered in Beijing, China.

About InnovAge

InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in its homes and communities. The company manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. It also offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to the PACE center and third-party medical appointments; and care management. The company serves participants in the United States; and operates PACE centers in Colorado, California, New Mexico, Pennsylvania, Florida, and Virginia. The company was formerly known as TCO Group Holdings, Inc. and changed its name to InnovAge Holding Corp. in January 2021. InnovAge Holding Corp. was founded in 2007 and is headquartered in Denver, Colorado.